Clinical evaluation of the efficacy of molindone and chlordiazepoxide in anxious outpatients.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001007:Anxiety; D002707:Chlordiazepoxide / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000139:chemically induced; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008972:Molindone / Q000009:adverse effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D014012:Tinnitus / Q000139:chemically induced
D000928:Antidepressive Agents; D007211:Indoles; D002707:Chlordiazepoxide; D008972:Molindone